Abstract

We report on the increased circulation of enterovirus A71 in Germany in 2019. Strains were mainly identified in hospitalised patients with suspected aseptic meningitis/encephalitis. Molecular analysis showed co-circulation of EV-A71 sub-genogroups C1 and C4, a signal for physicians and public health authorities to include/intensify EV diagnostic in patients showing signs of aseptic meningitis, encephalitis or acute flaccid paralysis/myelitis.

Highlights

  • We report on an increase of EV-A71 C1-like strains in Germany in 2019 and first detections of EV-A71 C4 strains in patients with neurological disease and HFMD

  • Stool or cerebrospinal fluid samples of hospitalised patients with signs of aseptic meningitis/encephalitis and/or acute flaccid paralysis are analysed within a quality-controlled laboratory network (LaNED)

  • Our findings suggest an increased circulation of EV-A71 strains in Germany already in the first 7 months of the year

Read more

Summary

Discussion and conclusion

Our findings suggest an increased circulation of EV-A71 strains in Germany already in the first 7 months of the year. Considering the fact that the EV season is still ongoing, the data available suggest that 2019 will become an epidemic year similar to 2016, 2013 and 2010. In Germany, the predominant EV-A71 sub-genogroup C2 was replaced by C1-like strains in 2016. Emergence of EV-A71 sub-genogroup C4 strains in Germany was detected between 2011 and 2013 [2], with France [10], Russia [11] and Denmark [12] reporting such detection around the same time. Since non-polio EV infections are not mandatorily notifiable at federal level in Germany, no data on severe cases or deaths are available. We were informed of an additional fatal case where EV-A71 was detected in a German child hospitalised in Austria in July 2019

Sub-genogroup C4
Conflict of interest
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.